Pelvic Floor Disorders

    Pelvic Floor Disorders (PFD) include a broad array of interrelated clinical conditions that include, urinary incontinence (UI), pelvic organ prolapse (POP), fecal incontinence (FI), sensory and emptying abnormalities of the lower urinary tract and defecatory dysfunction. Beyond the economic costs and general healthcare burden, PFD result in significant psychosocial costs and can have a profound impact on an individual’s quality of life [Landefeld 2008]. The prevalence of PFD increases with age and it is estimated that the growth in demand for services to care for women with PFD will increase at twice the rate of growth of the population over the next 30 years [Luber 2001].

    POP is the downward descent of the female pelvic organs (vagina, uterus, bladder and/or rectum) into or through the vagina. Loss of vaginal or uterine support in women presenting for routine gynecology care is seen in up to 43%-76% of women, with 3%-6% of those with descent beyond the hymen and approximately 3% of women developing symptomatic vaginal bulging [Nygaard 2008, Elerkmann 2001, Swift 2000]. POP is a prevalent condition that can substantially affect a woman’s daily living, quality of life, body image, sexual function and family relationships. Treatment options for women with prolapse are complex and often involve treating multiple concurrent disorders of bowel, bladder and sexual function, with the use of a pessary, observation,  or a surgical repair. Prolapse of the anterior vaginal wall, or cystocele, is the most common form of POP and the most likely to recur after surgery [Clark 2003]. 

    Non-Surgical Treatments

    Other than observation, pessary use is the principal non-surgical intervention available for women with POP. These devices are inserted into the vagina to reduce prolapsed tissue inside the vagina, to provide support to related pelvic structures, and to relieve pressure on the bladder and bowel in order to avert or delay the need for surgery [Wilson 2005, Adams 2004].

    Surgical Treatments

    A variety of surgeries exist for the surgical correction of POP including: transvaginal native-tissue (non-mesh) repairs, transvaginal mesh repairs and abdominal repairs (sacrolpopexy) using mesh or native tissue which can be performed via laparotomy, or via laparoscopy with or without robotic assistance. Reinforcement of vaginal repairs with synthetic mesh has been widely employed in the hope of improving the effectiveness and durability of vaginal prolapse repairs. Surgical mesh materials used to correct POP can be divided into four general categories: (a) non-absorbable synthetic (e.g., polypropylene or polyester); (b) absorbable synthetic [e.g., poly (lactic-co-glycolic acid) or poly (caprolactone)]; (c) biologic (e.g., acellular collagen derived from bovine or porcine sources); or, composite (i.e., a combination of any of the previous three categories). There is currently no consensus regarding which surgical approach is superior and each has its own risk-benefit profile. Most Female Pelvic Medicine and Reconstructive Surgery (FPMRS) specialists incorporate multiple different approaches in their practice, tailoring the specific technique to the individual patient and her unique characteristics and preferences.

    A 2011 Cochrane review evaluated 3,773 participants in 40 trials of different surgical procedures for POP made several conclusions including: 1) abdominal sacrocolpopexy had lower recurrent vault prolapse rates than native tissue repair using sacrospinous colpopexy but this was balanced against longer time to return to activities of daily life and higher complications; and 2) that native tissue repair was associated with more anterior compartment failures than transvaginal mesh grafts (overlay: RR 2.14 (95% CI 1.23-3.74; trocar guided kits RR 3.55, 95% CI 2.29-5.51) [Maher, 2011]. However, there was no difference in subjective outcomes, quality of life data, de novo dyspareunia, stress incontinence, reoperations for POP or UI although available data for these outcomes was limited. There was a higher rate of complications associated with vaginal mesh compared with native tissue vaginal repairs, including a 10% mesh erosion rate. Another systematic review analyzed the complications and reoperation rates for surgical procedures specifically performed to correct apical POP: native tissue vaginal repairs, sacrocolpopexy and vaginal mesh kits. In this review, the rate of reoperation to correct recurrent prolapse was lowest in those who received transvaginal mesh; however, reoperations for complications as well as the total reoperation rate was highest for vaginal mesh kits compared with vaginal native tissue and abdominal repairs, despite shorter overall follow-up [Diwadkar, 2009].

    Important Statistics

    • Nearly 1/4 of all women and more than 1/3 of older women report symptoms of at least one PFD, according to national population-based estimates [Nygaard 2008].
    • Approximately 1 in 9 women will undergo surgery for Urinary Incontinence and/or POP by age 80 with 30% of those women undergoing two or more surgical procedures [Olsen 1997].
    • Economic analyses estimate that the total cost of UI alone is up to $19.5 billion dollars (in year 2000) annually [Hu 2004].
    • When 237 women were evaluated for POP, they had concurrent PFDs such as [Ellkermann et al]:
      • 73% reported urinary incontinence
      • 86% reported urinary urgency and/or frequency
      • 34-62% reported voiding dysfunction
      • 31% complained of Fecal Incontinence
    • POP accounts for approximately 15%-18% of hysterectomies in the US and uterovaginal prolapse is the most common indication for hysterectomy in postmenopausal women [Jacobson 2006, Whiteman 2008].
    • A woman’s lifetime risk of surgery for POP is approximately 7% [Olsen 1997
    • 300,000 prolapse surgeries are performed annually in the United States. Of those an estimated 13% will require a repeat operation within 5 years, and an estimated 29% will undergo another surgery for genital prolapse or a related condition at some point during their life [Olsen 1997, Clark 2003].
    • Almost 1/4 of all prolapse repairs currently involve the placement of transvaginal mesh.
    • A recent randomized controlled trial (RCT) of 389 women assigned to anterior mesh or anterior colporrhaphy showed [Altman 2011]:
      • Higher success rates based on a composite outcome of subjective absence of a bulge and anatomic stage 0 or stage I prolapse
      • Higher success rates were seen with anterior mesh (60.8%) compared with native tissue anterior colporrhaphy (34.5%) at 1 year.
      • Rates of intraoperative bladder injury and hemorrhage were higher in the mesh group, and de novo stress incontinence also was higher (12.3% versus 6.3%).
      • Surgical re-intervention for mesh exposure was relatively low at 3.2%.

    logo.jpg

     

    1100 Wayne Avenue, Suite 670
    Silver Spring, MD 20910
    P: 301-273-0570 | F: 301-273-0778
    info@augs.org

     

    Copyright © 2017 American Urogynecologic Society. All Rights Reserved.